Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Picture a small, sleek robot following you around the kitchen, helping you multitask—something Apple intends to bring to life ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq ...

Arkansas Gov. Sarah Huckabee Sanders announced the "Healthy Moms, Healthy Babies Act," a multi-million dollar initiative ...